Replacement of the carboxylic acid group of prostaglandin F2α with a hydroxyl or methoxy substituent provides biologically unique compounds
Authors:
- 1 August 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 130 (8) , 1933-1943
Abstract
Replacement of the carboxylic acid group of PGF2α with the non‐acidic substituents hydroxyl (‐OH) or methoxy (‐OCH3) resulted in an unexpected activity profile. Although PGF2α 1‐OH and PGF2α 1‐OCH3 exhibited potent contractile effects similar to 17‐phenyl PGF2α in the cat lung parenchymal preparation, they were approximately 1000 times less potent than 17‐phenyl PGF2α in stimulating recombinant feline and human FP receptors. In human dermal fibroblasts and Swiss 3T3 cells PGF2α 1‐OH and PGF2α 1‐OCH3 produced no Ca2+ signal until a 1 μM concentration was exceeded. Pretreatment of Swiss 3T3 cells with either 1 μM PGF2α 1‐OH or PGF2α 1‐OCH3 did not attenuate Ca2+ signal responses produced by PGF2α or fluprostenol. In the rat uterus, PGF2α 1‐OH was about two orders of magnitude less potent than 17‐phenyl PGF2α whereas PGF2α 1‐OCH3 produced only a minimal effect. Radioligand binding studies on cat lung parenchymal plasma membrane preparations suggested that the cat lung parenchyma does not contain a homogeneous population of receptors that equally respond to PGF2α1‐OH, PGF2α1‐OCH3, and classical FP receptor agonists. Studies on smooth muscle preparations and cells containing DP, EP1, EP2, EP3, EP4, IP, and TP receptors indicated that the activity of PGF2α 1‐OH and PGF2α 1‐OCH3 could not be ascribed to interaction with these receptors. The potent effects of PGF2α 1‐OH and PGF2α 1‐OCH3 on the cat lung parenchyma are difficult to describe in terms of interaction with the FP or any other known prostanoid receptor. British Journal of Pharmacology (2000) 130, 1933–1943; doi:10.1038/sj.bjp.0703462Keywords
This publication has 32 references indexed in Scilit:
- Effects of BW A868C, a selective prostaglandin DP receptor antagonist, in dog isolated vascular preparationsEuropean Journal of Pharmacology, 1996
- A Novel Subtype of the Prostacyclin Receptor Expressed in the Central Nervous SystemJournal of Biological Chemistry, 1996
- Immortalization of cat iris sphincter smooth muscle cells by SV40 virus: Growth, morphological, biochemical and pharmacological characteristicsExperimental Eye Research, 1995
- Thromboxane A2 receptorsJournal of Lipid Mediators and Cell Signalling, 1995
- Functional characterization of the prostanoid DP receptor in human myometriumEuropean Journal of Pharmacology, 1995
- A study of prostacyclin mimetics distinguishes neuronal from neutrophil IP receptorsEuropean Journal of Pharmacology, 1995
- Identification of a single (FP) receptor associated with prostanoid-induced Ca2+ signals in swiss 3T3 cellsBiochemical Pharmacology, 1994
- Prostanoid receptors — the development of a working classificationTrends in Pharmacological Sciences, 1984
- Synthesis and biological activity of carboxyl-terminus modified prostaglandin analogsJournal of Medicinal Chemistry, 1979
- Amide and l-amino derivatives of F prostaglandins as prostaglandin antagonistsNature, 1978